Posaconazole for bone-invading rhinomaxillary mucormycosis

Otolaryngology - Head and Neck Surgery

Volumn 140, Issue 4, 2009, Pages 610-611

  Marom, Tal ^a   Watad, Waseem ^a   Dan, Michael ^a   Roth, Yehudah ^a,b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIHYPERTENSIVE AGENT; BRONCHODILATING AGENT; DIURETIC AGENT; POSACONAZOLE; STEROID;

AGED; ANGINA PECTORIS; ARTICLE; ASTHMA; CASE REPORT; CELLULITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DRUG MEGADOSE; DRUG WITHDRAWAL; ENDOSCOPY; ETHMOID SINUS; FEMALE; HISTOPATHOLOGY; HUMAN; MUCORMYCOSIS; NAUSEA; RHINOMAXILLARY MUCORMYCOSIS; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

AGED, 80 AND OVER; ANTIBIOTICS, ANTIFUNGAL; FEMALE; HUMANS; MAXILLARY DISEASES; MUCORMYCOSIS; PARANASAL SINUS DISEASES; TRIAZOLES;

EID: 62849120145     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2008.11.022     Document Type: Article

References (4)

1. Roden M.M., Zaoutis T.E., Buchanan W.L., et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41 (2005) 634-653
2. Diekema D.J., Messer S.A., Hollis R.J., et al. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 41 (2003) 3623-3626
3. Simmons J.H., Zeitler P.S., Fenton L.Z., et al. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature. Pediatr Diabetes 6 (2005) 234-238
4. Pandey A., George J., and Rao N.N. Mucormycosis causing extensive destruction of maxilla. Indian J Dent Res 15 (2004) 74-77